Hepatocellular Carcinoma Clinical Trials in Philadelphia, Pennsylvania
10 recruitingPhiladelphia, Pennsylvania
Showing 1–10 of 10 trials
Recruiting
Phase 1
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Solid Tumor+7 more
Exelixis1,314 enrolled122 locationsNCT05176483
Recruiting
Phase 2
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
Hepatocellular Carcinoma
Genentech, Inc.30 enrolled61 locationsNCT06096779
Recruiting
Phase 1Phase 2
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ovarian CarcinomaColorectal CarcinomaMelanoma+19 more
Children's Oncology Group147 enrolled21 locationsNCT04851119
Recruiting
Phase 1
SBRT With Atezo/Bev for HCC
Hepatocellular Carcinoma
Abramson Cancer Center at Penn Medicine18 enrolled1 locationNCT05488522
Recruiting
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Liver CancerCholangiocarcinomaHepatocellular Carcinoma
National Cancer Institute (NCI)500 enrolled7 locationsNCT04145141
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 2
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Biliary Tract CancerHepatocellular Carcinoma
Replimune Inc.60 enrolled11 locationsNCT05733598
Recruiting
An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
Unresectable Hepatocellular Carcinoma
Bayer300 enrolled20 locationsNCT06117891
Recruiting
Phase 2
Y-90 Treatment Response Using Transarterial Radioembolization
Liver CancerHepatocellular CarcinomaPrimary Liver Cancer+3 more
Thomas Jefferson University30 enrolled1 locationNCT07145801
Recruiting
Phase 1Phase 2
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Hepatocellular CarcinomaNeuroendocrine TumorsGastrointestinal Cancer Metastatic
Teclison Ltd.25 enrolled2 locationsNCT02174549